These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20238312)

  • 1. Tamoxifen for relapse of ovarian cancer.
    Williams C; Simera I; Bryant A
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD001034. PubMed ID: 20238312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen for relapse of ovarian cancer.
    Williams CJ
    Cochrane Database Syst Rev; 2001; (1):CD001034. PubMed ID: 11279703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen for relapse of ovarian cancer.
    Williams CJ
    Cochrane Database Syst Rev; 2000; (2):CD001034. PubMed ID: 10796734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
    Wuntakal R; Seshadri S; Montes A; Lane G
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Goel S; Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
    Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Morrison J; Thoma C; Goodall RJ; Lyons TJ; Gaitskell K; Wiggans AJ; Bryant A
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007927. PubMed ID: 30321910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
    Galaal K; Naik R; Bristow RE; Patel A; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007822. PubMed ID: 20556785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007927. PubMed ID: 21975775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.
    Abdul Razak AR; Li L; Bryant A; Diaz-Padilla I
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007584. PubMed ID: 21412906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-repair pathway inhibitors for the treatment of ovarian cancer.
    Martinek I; Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007929. PubMed ID: 20556786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exenterative surgery for recurrent gynaecological malignancies.
    Ang C; Bryant A; Barton DP; Pomel C; Naik R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010449. PubMed ID: 24497188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma.
    Shylasree TS; Bryant A; Athavale R
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006246. PubMed ID: 23450567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of drainage for malignant ascites in gynaecological cancer.
    Keen A; Fitzgerald D; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007794. PubMed ID: 20091648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.